Multivisceral cytoreductive surgery in FIGO stages IIIC and IV epithelial ovarian cancer: Results and 5-year follow-up
- 30 September 2007
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 106 (3) , 591-595
- https://doi.org/10.1016/j.ygyno.2007.05.023
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancerGynecologic Oncology, 2006
- Identification of Prognostic Factors in Advanced Epithelial Ovarian CarcinomaGynecologic Oncology, 2001
- Optimal Cytoreductive Surgery Is an Independent Prognostic Indicator in Stage IV Epithelial Ovarian Cancer with Hepatic MetastasesGynecologic Oncology, 2000
- Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian CancerGynecologic Oncology, 1999
- Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective StudyGynecologic Oncology, 1998
- Stage IV Ovarian Cancer: Impact of Surgical Debulking1Gynecologic Oncology, 1997
- Peritonectomy ProceduresAnnals of Surgery, 1995
- Epithelial Ovarian Carcinoma: Principles of Primary SurgeryGynecologic Oncology, 1994
- The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinomaGynecologic Oncology, 1992
- The changing prognosis and treatment in cancer of the ovaryAmerican Journal of Obstetrics and Gynecology, 1968